An experimental drug combination was able to effectively treat pancreatic cancer in mouse models without tumor resistance.

The findings show diligence from the FDA and a need for clinicians to discuss risks, benefits, and unknowns with patients before using drugs with accelerated approval.

Spanish scientists have created a new triple drug therapy that completely cures pancreatic cancer in mice. This experimental ...

Scientists in Spain say they have uncovered a cure for pancreatic cancer in mice. The breakthrough could help people ...

By targeting three key growth pathways at once, researchers eliminated pancreatic tumors in multiple mouse models and ...

For more than a century, everyday painkillers have been handed over pharmacy counters to ease headaches, joint aches and fevers. Now a wave of research is revealing that some of these familiar tablets ...

Good news for a grave concern. Researchers believe a groundbreaking new drug can offer hope to those diagnosed with this deadly breast cancer, creating a new standard of care and improved survival ...

“Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint ...

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...

Anti-acid medications being used over a long period of time may not increase stomach cancer risk, a new study has claimed. After decades of suggestions that proton pump inhibitors (PPIs) are linked to ...